These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
555 related articles for article (PubMed ID: 25805039)
1. Association of folate and other one-carbon related nutrients with hypermethylation status and expression of RARB, BRCA1, and RASSF1A genes in breast cancer patients. Pirouzpanah S; Taleban FA; Mehdipour P; Atri M J Mol Med (Berl); 2015 Aug; 93(8):917-34. PubMed ID: 25805039 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of promoter hypermethylation of RASSF1A, RARbeta2, BRCA1 and HOXA5 in breast cancers of Indian patients. Bagadi SA; Prasad CP; Kaur J; Srivastava A; Prashad R; Gupta SD; Ralhan R Life Sci; 2008 Jun; 82(25-26):1288-92. PubMed ID: 18538349 [TBL] [Abstract][Full Text] [Related]
3. Promoter Methylation of BRCA1, DAPK1 and RASSF1A is Associated with Increased Mortality among Indian Women with Breast Cancer. Yadav P; Masroor M; Nandi K; Kaza RCM; Jain SK; Khurana N; Saxena A Asian Pac J Cancer Prev; 2018 Feb; 19(2):443-448. PubMed ID: 29480000 [TBL] [Abstract][Full Text] [Related]
4. Promoter methylation of E-cadherin, p16, and RAR-β(2) genes in breast tumors and dietary intake of nutrients important in one-carbon metabolism. Tao MH; Mason JB; Marian C; McCann SE; Platek ME; Millen A; Ambrosone C; Edge SB; Krishnan SS; Trevisan M; Shields PG; Freudenheim JL Nutr Cancer; 2011; 63(7):1143-50. PubMed ID: 21916701 [TBL] [Abstract][Full Text] [Related]
5. Different methylation and microRNA expression pattern in male and female familial breast cancer. Pinto R; Pilato B; Ottini L; Lambo R; Simone G; Paradiso A; Tommasi S J Cell Physiol; 2013 Jun; 228(6):1264-9. PubMed ID: 23160909 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients. Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789 [TBL] [Abstract][Full Text] [Related]
7. Gene methylation in breast ductal fluid from BRCA1 and BRCA2 mutation carriers. Antill YC; Mitchell G; Johnson SA; Devereux L; Milner A; Di Iulio J; Lindeman GJ; Kirk J; Phillips KA; Campbell IG Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):265-74. PubMed ID: 20056647 [TBL] [Abstract][Full Text] [Related]
8. Association between HIC1 and RASSF1A promoter hypermethylation with MTHFD1 G1958A polymorphism and clinicopathological features of breast cancer in Iranian patients. Rasti M; Tavasoli P; Monabati A; Entezam M Iran Biomed J; 2009 Oct; 13(4):199-206. PubMed ID: 19946345 [TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation of p16, BRCA1 and RASSF1A genes in triple-negative breast cancer patients from Serbia. Kozomara Z; Supic G; Krivokuca A; Magic Z; Dzodic R; Milovanovic Z; Brankovic-Magic M J BUON; 2018; 23(3):684-691. PubMed ID: 30003738 [TBL] [Abstract][Full Text] [Related]
10. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance. Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230 [TBL] [Abstract][Full Text] [Related]
11. The effect of modifiable potentials on hypermethylation status of retinoic acid receptor-beta2 and estrogen receptor-alpha genes in primary breast cancer. Pirouzpanah S; Taleban FA; Atri M; Abadi AR; Mehdipour P Cancer Causes Control; 2010 Dec; 21(12):2101-11. PubMed ID: 20711807 [TBL] [Abstract][Full Text] [Related]
12. Silencing of tumor suppressor genes RASSF1A, SLIT2, and WIF1 by promoter hypermethylation in hereditary breast cancer. Alvarez C; Tapia T; Cornejo V; Fernandez W; Muñoz A; Camus M; Alvarez M; Devoto L; Carvallo P Mol Carcinog; 2013 Jun; 52(6):475-87. PubMed ID: 22315090 [TBL] [Abstract][Full Text] [Related]
13. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients. Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006 [TBL] [Abstract][Full Text] [Related]
14. Associations of dietary methyl donor intake with MLH1 promoter hypermethylation and related molecular phenotypes in sporadic colorectal cancer. de Vogel S; Bongaerts BW; Wouters KA; Kester AD; Schouten LJ; de Goeij AF; de Bruïne AP; Goldbohm RA; van den Brandt PA; van Engeland M; Weijenberg MP Carcinogenesis; 2008 Sep; 29(9):1765-73. PubMed ID: 18339680 [TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients. Sharma G; Mirza S; Yang YH; Parshad R; Hazrah P; Datta Gupta S; Ralhan R Cell Oncol; 2009; 31(6):487-500. PubMed ID: 19940364 [TBL] [Abstract][Full Text] [Related]
17. Dietary folate, vitamin B6, vitamin B12 and methionine intake and the risk of breast cancer by oestrogen and progesterone receptor status. Zhang CX; Ho SC; Chen YM; Lin FY; Fu JH; Cheng SZ Br J Nutr; 2011 Sep; 106(6):936-43. PubMed ID: 21736840 [TBL] [Abstract][Full Text] [Related]
18. DNA methylation and breast tumor clinicopathological features: The Western New York Exposures and Breast Cancer (WEB) study. Callahan CL; Wang Y; Marian C; Weng DY; Eng KH; Tao MH; Ambrosone CB; Nie J; Trevisan M; Smiraglia D; Edge SB; Shields PG; Freudenheim JL Epigenetics; 2016 Sep; 11(9):643-652. PubMed ID: 27245195 [TBL] [Abstract][Full Text] [Related]
19. Role of physical activity in modulating breast cancer risk as defined by APC and RASSF1A promoter hypermethylation in nonmalignant breast tissue. Coyle YM; Xie XJ; Lewis CM; Bu D; Milchgrub S; Euhus DM Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):192-6. PubMed ID: 17301249 [TBL] [Abstract][Full Text] [Related]
20. Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer. van Engeland M; Weijenberg MP; Roemen GM; Brink M; de Bruïne AP; Goldbohm RA; van den Brandt PA; Baylin SB; de Goeij AF; Herman JG Cancer Res; 2003 Jun; 63(12):3133-7. PubMed ID: 12810640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]